[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.146.179.146. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Views 1,034
Citations 0
Comment & Response
February 10, 2015

Contact Precautions for Patients With Multidrug-Resistant Pathogens

Author Affiliations
  • 1Department of Intensive Care, University Medical Center Utrecht, Utrecht, the Netherlands
  • 2Nuffield Department of Clinical Medicine, University of Oxford, Oxford, England
  • 3Service de réanimation médicale, APHP GH Henri Mondor/ Université Paris Est-Créteil, Creteil, France
JAMA. 2015;313(6):629-630. doi:10.1001/jama.2014.17439

To the Editor In their recent Viewpoint, Dr Morgan and colleagues1 suggested that contact precautions for patients colonized or infected with methicillin-resistant Staphylococcus aureus (MRSA) or vancomycin-resistant Enterococcus (VRE) should be reconsidered until more evidence of their efficacy becomes available, thereby questioning the wisdom of mandatory screening for MRSA. Morgan et al called for “a high-quality quasi-experimental study or cluster-randomized trial comparing the effect of adding contact precautions to the assiduous application of standard precautions on MRSA and VRE infections.”

First Page Preview View Large
First page PDF preview
First page PDF preview
×